This aligned with data from the lab suggested that the neuroinflammation is observed in P301S and impacts the early behavioral changes prior to tau aggregation [39], suggesting that the modulation of inflammatory insult in P301S can successfully mitigate the cognitive impairment. The gene discussed is MAPT; the disease is Cognitive impairment.